Testing guidelines and strategies by ICMR: a roadmap to handle COVID-19 pandemic in India

Authors

  • Neha Mantri School of Public Health, AIIMS, Jodhpur, Rajasthan, India
  • Manoj Kumar Gupta Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India
  • Pankaj Bhardwaj Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India
  • Akhil D. Goel Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India
  • Suman Saurabh Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India
  • Vidhi Jain Department of Microbiology, Jodhpur, Rajasthan, India
  • Vijay Lakshmi Nag Department of Microbiology, Jodhpur, Rajasthan, India
  • Sanjeev Misra AIIMS, Jodhpur, Rajasthan, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20220701

Keywords:

COVID-19, Laboratory, Pandemic, Testing

Abstract

Background: Since the inception of the COVID-19 pandemic, the cases are continuously increasing in India. Though this growth of the cases was relatively slower during the initial phase of the pandemic, now the cases are increasing rapidly and positioned the country at third place in the world in the COVID-19 tally. This study was done to review all the guidelines and strategies released by the ICMR and MoH and FW, Government of India, in regard with the testing of COVID-19 in the country and to collate them with timelines.

Methods: Country-level data was retrieved from the crowdsourced database and was analyzed descriptively to calculate the cumulative and per day test positivity rates.

Results: A sharp rise in the test positivity rate was observed until the first week of April, which declined slightly during the next month. After that, the test positive rate is found to be continuously increasing. At the same time, the testing capacity of the country has also increased from about 250 tests per day at the beginning of March to 6.42 lac per day by the end of July. ICMR put a lot of effort into the expansion of the laboratory network to ramp up the COVID-19 testing capacity in the country. Without having any delay, dynamic guidelines, and strategies for testing with a lot of innovations were developed and implemented maintaining all the quality and safety parameters.

Conclusions: ICMR worked tirelessly on the forefront to devise a roadmap to handle the COVID-19 pandemic in India through the development of testing strategies and guidelines.

Metrics

Metrics Loading ...

References

Bhatia S. Corona fear in India higher than in West, lower than in other parts of Asia [Internet]. Livemint. Available at: https://www.livemint.com/news/ india/corona-fear-in-india-higher-than-in-west-lower-than-in-other-parts-of-asia-11588350337151.html. Accessed on 20 October 2021.

Coronavirus Update (Live): 18,471,207 Cases and 697,955 Deaths from COVID-19 Virus Pandemic - Worldometer. Available at: https://www.worldo meters.info/coronavirus/. Accessed on 20 October 2021.

Coronavirus in India: Latest map and case count. Available at: https://www.covid19india.org. Accessed on 20 October 2021.

Coronavirus. Available at: https://www.mohfw. gov.in/. Accessed on 20 October 2021.

COVID-19. Available at: https://www.icmr.gov.in/. Accessed on 20 October 2021.

Information for COVID-19 Testing Labs. Available at: https://www.icmr.gov.in/ctestlab.html. Accessed on 20 October 2021.

Diagnostic Kit Evaluation. Available at: https://www. icmr.gov.in/ckitevaluation.html. Accessed on 20 October 2021.

Testing Strategy. Available at: https://www.icmr. gov.in/cteststrat.html. Accessed on 20 October 2021.

WHO. Real-time RT-PCRassays forthe detection ofSARS-CoV-2InstitutPasteur, Paris . Available at: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2. Accessed on 20 October 2021.

Covid L. Accelerated Emergency Use Authorization (EUA) summary COVID-19 RT-PCR Test; Available at: https://www.fda.gov/media/136151/download. Accessed on 20 October 2021.

Xpert® Xpress SARS-CoV-2. Available at: https://www.fda.gov/media/136314/download. Accessed on 20 October 2021.

ICMR. Revised Guidelines for TrueNat testing for COVID-19. Available at: https://www.icmr.gov.in/ pdf/covid/labs/Revised_Guidelines_TrueNat_Testing_19052020.pdf. Accessed on 20 October 2021.

Molbio Diagnostics. Available at: http://www.molbio diagnostics.com/product_details.php?id=54. Accessed on 20 October 2021.

ICMR. ASPEN SARS CoV-2 IgG ELISA. Available at: https://www.icmr.gov.in/pdf/covid/kits/ ELISA_ CLIA_Kits_List_07082020.pdf. Accessed on 20 October 2021.

Interpreting a covid-19 test result. Available at: https://pubmed.ncbi.nlm.nih.gov/32398230/. Accessed on 20 October 2021.

TruenatTM Beta CoV: Chip-based Real Time PCR Test for Beta Coronavirus. Available at: http://www.molbiodiagnostics.com/uploads/product_download/20200414.110511~Truenat-Beta-Coronavirus-packinsert-VER-03.pdf. Accessed on 20 October 2021.

Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui L-P, Johnston JC, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020;370:m2516.

Downloads

Published

2022-02-28

How to Cite

Mantri, N., Gupta, M. K., Bhardwaj, P., Goel, A. D., Saurabh, S., Jain, V., Nag, V. L., & Misra, S. (2022). Testing guidelines and strategies by ICMR: a roadmap to handle COVID-19 pandemic in India. International Journal Of Community Medicine And Public Health, 9(3), 1394–1400. https://doi.org/10.18203/2394-6040.ijcmph20220701

Issue

Section

Original Research Articles